FimmCyte

FimmCyte is a women's health technology company focused on developing new therapies for endometriosis, and is a biotechnology spin-off from the University of Zurich and Zurich University Hospital. The company concentrates on developing antibody-based treatments for women's health, with an initial focus on endometriosis, a complex fibro-inflammatory disease.